PI3K Stimulates DNA Synthesis and Cell-Cycle Progression via Its p55PIK Regulatory Subunit Interaction with PCNA

被引:39
作者
Wang, Guihua [1 ,2 ]
Cao, Xiaonian [1 ]
Lai, Senyan [1 ]
Luo, Xuelai [1 ]
Feng, Yongdong [2 ]
Xia, Xianmin [1 ]
Yen, Paul M. [3 ]
Gong, Jianping [2 ]
Hu, Junbo [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Hosp, Canc Res Inst, Wuhan 430030, Peoples R China
[2] Huazhong Univ Sci & Technol, Tongji Hosp, Mol Med Ctr, Wuhan 430030, Peoples R China
[3] Duke Natl Univ Singapore, Grad Sch Med, Lab Hormonal Regulat, Cardiovasc & Metab Dis Program, Singapore, Singapore
关键词
PHOSPHOINOSITIDE 3-KINASE BETA; HIGH-FREQUENCY; CANCER; PROLIFERATION; INHIBITOR; MUTATIONS; P85-ALPHA; ISOFORM; PATHWAY; TARGET;
D O I
10.1158/1535-7163.MCT-12-0920
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Previously, we have shown that p55PIK, an isoform of class I-A phosphoinositide 3-kinase (PI3K), specifically interacts with important cell-cycle regulators, such as retinoblastoma (Rb), to promote cell-cycle progression. Here, we used the glutathione S-transferase pull-down assay to identify other p55PIK-interacting proteins besides Rb in a Rb-deficient cell line and found that p55PIK interacted with proliferation cell nuclear antigen (PCNA), which plays a key role in coordinating both initiation of the leading strand DNA replication and discontinuous lagging strand synthesis. Overexpression of p55PIK increased, and knockdown decreased, DNA synthesis and DNA replication by modulating the binding of DNA polymerase delta (Pol delta) to PCNA. Moreover, a cell-permeable peptide containing the N-terminal-binding domain of p55PIK (TAT-N24) disrupted the p55PIK-PCNA interaction in cancer cells, and also inhibited the DNA synthesis and tumor growth in cell culture and in vivo. Altogether, our results show that the p55PIK-PCNA interaction is important in regulating DNA synthesis and contributes to tumorigenesis. Furthermore, the p55PIK-PCNA interaction provides a potential new target for anticancer drug development. (c) 2013 AACR.
引用
收藏
页码:2100 / 2109
页数:10
相关论文
共 29 条
[1]   Filarial Lymphatic Pathology Reflects Augmented Toll-Like Receptor-Mediated, Mitogen-Activated Protein Kinase-Mediated Proinflammatory Cytokine Production [J].
Babu, Subash ;
Anuradha, R. ;
Kumar, N. Pavan ;
George, P. Jovvian ;
Kumaraswami, V. ;
Nutman, Thomas B. .
INFECTION AND IMMUNITY, 2011, 79 (11) :4600-4608
[2]   The Regulation of Class IA PI 3-Kinases by Inter-Subunit Interactions [J].
Backer, Jonathan M. .
PHOSPHOINOSITIDE 3-KINASE IN HEALTH AND DISEASE, VOL 1, 2010, 346 :87-114
[3]   Oncogenic PI3K deregulates transcription and translation [J].
Bader, AG ;
Kang, SY ;
Zhao, L ;
Vogt, PK .
NATURE REVIEWS CANCER, 2005, 5 (12) :921-929
[4]   A selective inhibitor of the p110δ isoform of PI 3-kinase inhibits AML cell proliferation and survival and increases the cytotoxic effects of VP16 [J].
Billottet, C. ;
Grandage, V. L. ;
Gale, R. E. ;
Quattropani, A. ;
Rommel, C. ;
Vanhaesebroeck, B. ;
Khwaja, A. .
ONCOGENE, 2006, 25 (50) :6648-6659
[5]   Phosphoinositide signalling in cancer: beyond PI3K and PTEN [J].
Bunney, Tom D. ;
Katan, Matilda .
NATURE REVIEWS CANCER, 2010, 10 (05) :342-352
[6]   Direct positive regulation of PTEN by the p85 subunit of phosphatidylinositol 3-kinase [J].
Chagpar, Ryaz B. ;
Links, Philip H. ;
Pastor, M. Chris ;
Furber, Levi A. ;
Hawrysh, Andrea D. ;
Chamberlain, M. Dean ;
Anderson, Deborah H. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (12) :5471-5476
[7]   The PI3K Pathway As Drug Target in Human Cancer [J].
Courtney, Kevin D. ;
Corcoran, Ryan B. ;
Engelman, Jeffrey A. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (06) :1075-1083
[8]   PI3K/PTEN/AKT signaling regulates prostate tumor angiogenesis [J].
Fang, Jing ;
Ding, Min ;
Yang, Lily ;
Liu, Ling-Zhi ;
Jiang, Bing-Hua .
CELLULAR SIGNALLING, 2007, 19 (12) :2487-2497
[9]   Structure of the C-terminal region of p21(WAF1/CIP1) complexed with human PCNA [J].
Gulbis, JM ;
Kelman, Z ;
Hurwitz, J ;
ODonnell, M ;
Kuriyan, J .
CELL, 1996, 87 (02) :297-306
[10]   A peptide inhibitor derived from p55PIK phosphatidylinositol 3-kinase regulatory subunit: a novel cancer therapy [J].
Hu, Junbo ;
Xia, Xianmin ;
Cheng, Aiwu ;
Wang, Guihua ;
Luo, Xuelai ;
Reed, Michael F. ;
Fojo, Tito ;
Oetting, Alexis ;
Gong, Jianping ;
Yen, Paul M. .
MOLECULAR CANCER THERAPEUTICS, 2008, 7 (12) :3719-3728